Lisinopril and bradycardia
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Bradycardia: Clinical Case Reports and Drug Interactions
Several case reports have documented bradycardia in patients taking lisinopril, especially when combined with other medications. Notably, severe bradycardia and hypotension have been observed in elderly patients when tizanidine, a muscle relaxant, is added to long-term lisinopril therapy. In these cases, discontinuation of tizanidine and supportive care led to improvement in heart rate and blood pressure, highlighting a potentially dangerous interaction between tizanidine and lisinopril that can result in life-threatening bradycardia and hypotension. Healthcare providers should be cautious when prescribing these drugs together, as the combination can significantly increase the risk of bradycardia and hypotension, particularly in older adults or those with multiple comorbidities Publow2010Setzer2025.
Lisinopril, Bradycardia, and Age-Related Effects
Animal studies have shown that the effects of lisinopril on heart rate and reflex bradycardia can vary with age. In older rats, short-term lisinopril treatment further impaired angiotensin-induced reflex bradycardia, while younger rats did not experience this effect. Chronic lisinopril treatment enhanced reflex bradycardia in younger rats but had diminished effects in older rats, suggesting that the cardiovascular response to lisinopril, including its impact on bradycardia, is reduced with advancing age Montemayor1997Buñag1999.
Lisinopril and Reflex Control of Heart Rate in Humans
In studies involving healthy human volunteers, lisinopril and similar ACE inhibitors lowered blood pressure without causing a compensatory increase in heart rate. Instead, these drugs impaired certain parasympathetic reflexes that normally slow the heart, such as the diving reflex and the cardiac acceleration associated with lying down. This suggests that lisinopril may increase parasympathetic activity or alter reflex control of heart rate, potentially contributing to bradycardia in some individuals .
Lisinopril, Bradycardia, and Comorbid Conditions
Bradycardia associated with lisinopril may be more likely in patients with other risk factors, such as renal failure, hyperkalemia, or concurrent use of atrioventricular nodal blockers (e.g., beta-blockers). For example, in BRASH syndrome (Bradycardia, Renal failure, AV-nodal blockade, Shock, and Hyperkalemia), the combination of lisinopril with other medications and underlying conditions can precipitate severe bradycardia that is resistant to standard treatments .
Lisinopril and Cardiac Protection
In animal models of drug-induced cardiotoxicity, lisinopril has shown some protective effects against bradycardia and other cardiac changes, suggesting a potential benefit in certain contexts. However, these findings are primarily experimental and may not directly translate to clinical practice .
Lisinopril in Patients with Liver Disease
In patients with liver disease, lisinopril has a stronger blood pressure-lowering effect compared to some other ACE inhibitors, but there is no direct evidence linking lisinopril to increased bradycardia in this population. Beta-blockers, on the other hand, are more likely to cause bradycardia, especially those metabolized by the liver .
Conclusion
Lisinopril is generally not associated with bradycardia when used alone, but the risk increases when combined with other medications such as tizanidine or in the presence of comorbidities like renal failure and hyperkalemia. Age and underlying health conditions can also influence the likelihood and severity of bradycardia. Clinicians should monitor for bradycardia, especially in high-risk patients or when adding new medications to a regimen that includes lisinopril.
Sources and full results
Most relevant research papers on this topic
Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy.
Concomitant tizanidine and lisinopril therapy can cause severe hypotension and bradycardia in patients with pre-existing medical conditions.
DOI